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Abstract
Atherosclerosis is a complex disease in which vessels develop plaques comprising dysfunctional endothelium,
monocyte derived lipid laden foam cells and activated lymphocytes. Considering that humans and animal models of
the disease develop quite distinct plaques, we used human plaques to search for proteins that could be used as
markers of human atheromas. Phage display peptide libraries were probed to fresh human carotid plaques, and a
bound phage homologous to plexin B1, a high affinity receptor for CD100, was identified. CD100 is a member of the
semaphorin family expressed by most hematopoietic cells and particularly by activated T cells. CD100 expression
was analyzed in human plaques and normal samples. CD100 mRNA and protein were analyzed in cultured
monocytes, macrophages and foam cells. The effects of CD100 in oxLDL-induced foam cell formation and in CD36
mRNA abundance were evaluated. Human atherosclerotic plaques showed strong labeling of CD100/SEMA4D.
CD100 expression was further demonstrated in peripheral blood monocytes and in in vitro differentiated
macrophages and foam cells, with diminished CD100 transcript along the differentiation of these cells. Incubation of
macrophages with CD100 led to a reduction in oxLDL-induced foam cell formation probably through a decrease of
CD36 expression, suggesting for the first time an atheroprotective role for CD100 in the human disease. Given its
differential expression in the numerous foam cells and macrophages of the plaques and its capacity to decrease
oxLDL engulfment by macrophages we propose that CD100 may have a role in atherosclerotic plaque development,
and may possibly be employed in targeted treatments of these atheromas.
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Introduction
Atherosclerosis is one of the most prevalent diseases
worldwide. Atherosclerotic lesions are present as asymmetrical
focal thickenings of the intima, the innermost layer of the artery,
and result from focal accumulation of blood-borne inflammatory
and immune cells, vascular endothelial cells, extracellular
matrix, lipids and acellular lipid-rich debris [1].
Macrophages and foam cells are the most abundant cell type
in the atheromas although T cells are also present in a
significant number especially at the early stages [2]. Foam cells
differentiate from activated macrophages that express
scavenger receptors (SR) which uptake cholesteryl esters that
accumulate in the cytosol [3]. Scavenger receptors clear
residual components and are additionally involved in lipid
metabolism, binding modified low-density lipoproteins (LDL) [4].
Unlike the native LDL receptor, SR such as CD36 are not
down-regulated by increases of intracellular cholesterol levels,
resulting in a continued uptake of modified LDL and foam cell
formation [5].
Identifying markers of atherosclerotic plaques may be very
useful to improve diagnosis and treatment. In fact, diagnosis of
the disease usually occurs in an advanced stage (vulnerable
plaques), and treatment is quite invasive. The human
vulnerable plaque is one of the toughest cases in model design
and none of the available animal models seem to precisely
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reproduce it [6]. Considering this, we decided to search for
markers of human fresh carotid plaques using phage display
peptide libraries, which are efficient tools for the identification of
markers for several tissues and cell types [7–10]. Among the
phages that bound to two different human plaques after
subtraction using two different normal carotids we found
sequences homologous to plexins and semaphorins. One of
them was homologous to plexin B1, a high affinity receptor for
the semaphorin CD100.
Semaphorins are secreted and membrane-associated
proteins characterized by a conserved amino-terminal SEMA
domain, and are divided in eight subclasses [11]. CD100/
SEMA4D belongs to the class 4 of semaphorins, and is the
only for which membrane and soluble forms endow distinct
functional properties [12]. It is expressed on the majority of
hematopoietic cells (B, T, NK and myeloid cells), and
expression generally increases after cell activation [12]. T
lymphocytes express the highest levels of CD100 [13,14],
followed by platelets [15,16] and monocytes [17], all of which
can be found in human plaques. Tumor associated
macrophages also express CD100, being associated with
tumor vascularization, growth and metastases [18]. Human
CD100 was shown to influence migration and cytokine
production in monocytes [19], and is involved in T cell
activation and B cell survival. Monocytes express higher levels
of CD100 when stimulated with IFN-γ, a central cytokine in
atherosclerosis [1,13].
Differently from humans, murine CD100 couples to CD72
expressed in B lymphocytes and APCs, participating in the
interactions between these cells and shutting off negative
restraining signs in B cells [12], thus modulating humoral
responses [12,20]. A few studies have been performed to
establish a possible role for CD100 in the development of
atherosclerosis in the mice model; they have shown that lack of
Sema4D reduces platelet hyperactivity otherwise found in
dyslipidemia, thus conferring protection against atherosclerosis
[15]. Moreover Sema4D-/-ApoE-/- mice presented decreased
lipid staining, macrophage infiltration and intimal
neovascularization in the aortic plaques, suggesting that
Sema4D facilitates plaque growth by promoting
neovascularization through induction of endothelial cell
migration [21]. Nonetheless, there are still no reports about
CD100 expression in human atherosclerotic plaques.
Furthermore, there is no evidence of CD100 expression in
cultured or tissue human macrophages besides the ones found
in the tumoral environment.
Considering the binding of CD100 high affinity receptor to
plaques revealed by phage display and the molecule’s
angiogenic and immunological roles, we sought to evaluate
CD100 expression in human atherosclerotic lesions.
Immunohistochemical analysis indicated strong CD100
expression in macrophages and foam cells, as well as in
cultured macrophages and in in vitro differentiated foam cells.
Peripheral blood (PB) monocytes stimulated with IFN-γ
presented augmented CD100 transcripts, and CD100 RNA
abundance was inversely correlated to monocyte-macrophage-
foam cell differentiation in PB derived cells. Contrarily to the
pro-atherogenic effect of CD100 described in mice models [21],
we observed a possible anti-atherogenic effect of soluble
CD100 by the reduction of oxLDL-induced foam cell formation,
presumably by the observed decrease in CD36 expression.
Methods
Ethics Statement
Informed written consent was obtained from each patient/
family before collection of samples and the study protocol
conforms to the ethical guidelines of the Hospital das Clínicas
(HC - University of São Paulo School of Medicine) Human
Research Committee.
Human specimen collection
Four normal carotid samples were obtained from donors of
the Organ Transplantation of the Hospital das Clínicas of the
São Paulo School of Medicine (controls with no vascular
disease). Researchers involved in the project were present
during heart removal from the donor and received a fresh
fragment of approximately 5cm of the carotid that would not be
used for transplantation. The fragment was divided in two
pieces: one was transferred to 10% formalin for paraffin
embedding and the other was kept in DME medium for phage
display subtraction procedure. The family of the donors had
previously signed an authorization form specific for this project
donating the artery fragment to the “Laboratory of Immunology,
Heart Institute”. Twenty seven carotid plaques were obtained
from endarterectomies at the Heart Institute of São Paulo.
Patients with infectious diseases, cancer, malignant arterial
hypertension, previous surgical intervention in the same local,
previously transplanted or immunosuppressed were excluded.
Carotid plaques used for panning were classified as AHA 5B/C
(plaque with calcification and low lipid levels) and 5A (plaque
with fibrous cap) (Stary et al., 1994 [22]; Stary et al., 1995 [23]).
The plaque shown in immunohistochemistry/
immunofluorescence experiments belongs to the same AHA 5A
classification. Paraffin sections of a coronary plaque and a
normal coronary artery were gently provided by Dr Lourdes
Higuchi. Coronary fragments were collected post-mortem
(autopsies) of patients who died of acute myocardial infarction
at the Heart Institute, Incor - Hospital of the Faculty of
Medicine, University of São Paulo, between 1985 and 1999. At
the time of death the family signed a consent form authorizing
the autopsy pathology service in the same institution. This
authorization form allowed the use of this material for further
research. Collection of both samples (carotid and coronary
arteries) was approved by the Heart Institute Scientific
Committee and CAPPesq (Hospital das Clinicas Ethics
Committee).
Phage Display
The phage peptide library CX7C used in this project was
produced by Dr. Wadih Arap, Dr. Renata Pasqualini (MD
Anderson Cancer Center, USA) and Dr. Erkki Koivunen
(Helsinke University, Finland). The pre-clearing (subtraction)
step was done in a normal fresh carotid artery pre-washed in
DME medium and blocked with DME with 3% BSA for 15
CD100 in Human Atheromas
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minutes in ice. 109 TU library phages in 100 µL of DME with 3%
BSA were incubated with the luminal face of the normal carotid
for 30 minutes. Unbound phages were recovered and
incubated for 2 hours with the luminal face of a fresh carotid
plaque previously blocked with DME containing 3% BSA. The
plaque was carefully washed with DME and bound phages
were recovered by infection with E. coli K91kan, amplified and
precipitated using PEG/NaCl. These two steps were repeated
using a different normal carotid for pre-clearing and another
plaque for panning. After the two cycles of pre-clearing and
panning (selection), 100 phages were randomly selected and
sequenced. Peptide sequences were translated using Expasy,
aligned using ClustalW and compared to known sequences
using BLASTp.
Cell culture
Peripheral blood (PB) mononuclear cells were obtained by
density gradient centrifugation with Ficoll (Invitrogen, Carlsbad,
CA) and human monocytes were purified by positive selection
using anti-CD14 magnetic beads (Miltenyi Biotec, Germany).
Purity of monocytes was above 97% as verified by flow
cytometry analysis. Human T lymphocytes were purified by
negative selection using Pan T Isolation kit (Miltenyi Biotec,
Germany). PB monocytes macrophages and foam cells were
cultured in RPMI-1640 (Gibco, NY) containing 10% (v/v) calf
serum (Hy Clone, Utah), 10mM HEPES, 1mM glutamine,
200U/mL penicillin, 2mg/mL streptomycin and 1mM sodium
pyruvate. T lymphocytes were cultured in DMEM (Gibco, NY)
with 10% (v/v) calf serum (Hy Clone, Utah), 10mM HEPES,
1mM glutamine, 200U/mL penicillin, 2mg/mL streptomycin,
1mM sodium pyruvate and IL-2, IL-7 e IL-15 (R&D,
Minneapolis, MN) 40U/mL each.
PB monocytes were differentiated to macrophages with
20ng/mL Macrophage Colony Stimulating Factor (M-CSF)
(Peprotech, Rocky Hill, NJ) for 7 days. Macrophages were
differentiated into foam cells using a protocol adapted from
Banka et al., 1991 [24], by incubation with oxLDL (50μg/ml) for
48h. oxLDL was gently provided by Dr Claudia Andrade from
the Vascular Biology Laboratory, Heart Institute (InCor), São
Paulo, Brazil. LDL was isolated from whole blood of healthy
volunteers and oxidized as described by Cominacini et al.,
2000 [25]. Briefly, whole blood was collected into tubes
containing EDTA (1 mg/ml), centrifuged at 2000 rpm for 20 min
at 4°C and processed for LDL separation by sequential flotation
in NaBr solution containing 1 mg/ml EDTA. LDL was separated
by gel filtration on PD-10 Sephadex G-25M gel in 10 mM
phosphate-buffered saline. OxLDL was obtained by exposure
to 5 mM CuSO4 for 18 h at 37°C. The extent of LDL oxidation
procedure was determined by evaluating the level of
thiobarbituric acid-reactive substances.
For stimulation, monocytes, macrophages and foam cells
were seeded at 1.5x106/1.5mL/well in 6-well plates and T
lymphocytes at 2x106/1.0mL/well in 24-well plates (Costar,
Cambridge, MA). Monocytes, macrophages and foam cells
were stimulated with IFN-γ 100U/mL (Peprotech, Rocky Hill,
NJ) for 3h. T lymphocytes were activated CD3/CD28 beads
(MACS, Myilteni Biotec, Germany) 0.625µL/mL for 24h.
Immunohistochemistry
Tissue sections were subjected to antigen recovery with Tris-
EDTA buffer in Pascal pan and blocked with Protein Block
(DAKO, Glostrup, Denmark). After incubation with the primary
antibodies anti-CD100 1:1400 (BD Transduction, San Jose,
CA) or anti-CD68 1:300 (Santa Cruz, Santa Cruz, CA) in PBS
1% (w/v) BSA for 18h at 4°C, the samples were submitted to
LSAB (DAKO, Glostrup, Denmark) procedure (biotin for 1h and
streptavidin for 30min, both at 37°C). They were next incubated
with DAB (DAKO, Glostrup, Denmark) for 1min30s and in Scott
water for 30s, dehydrated through passages in alcohol and
xylol and mounted with Entellan (Merck, Darmstadt, Germany).
Positive controls were done using spleen sections in the same
conditions mentioned above, and negative controls were
performed using the same carotid/ coronary normal arteries
and plaque sections and only LSAB (secondary antibody).
CD100 labeling was also performed in thyroid tissue, used as
negative control tissue. The digitalization of the images was
made with the program AxioVision (Carl Zeiss Inc., Jena,
Germany).
Immunofluorescence
Tissue sections and cultured cells were blocked for 1h at
room temperature with Protein Block (DAKO, Glostrup,
Denmark) or with PBS 1% BSA and incubated with the primary
antibodies anti-SEMA4D (clone 3B4, Abnova, Taipei, Taiwan)
and anti-CD68 (mouse anti-human: clones PG-M1 and KP1,
DAKO, Glostrup, Denmark; rabbit anti-human: clone H-255,
Santa Cruz, CA) in PBS 1% (w/v) BSA at 4°C for 18h. After
washing, slides or coverslips were incubated with the
secondary antibodies for 90min at 4°C: Alexa Fluor 660 goat
anti-mouse IgG (Invitrogen, Carlsbad, CA), FITC anti-rabbit IgG
(Vector, Burlingame, CA) or Alexa Fluor 433 goat anti-rabbit
IgG (Invitrogen, Carlsbad, CA). For cultured cells, culture
medium was aspirated, and coverslips were washed three
times with PBS. Cells were fixed with 2% paraformaldehyde for
30 min at RT or for 15 min at 37 °C. After washing steps with
PBS the cells were permeabilized in PBS 0.1% Nonidet P40 for
30 min at RT or 15 minutes at 37 °C. After blocking, coverslips
were then incubated with the primary and secondary antibodies
as described above. Glass slides and coverslips were mounted
with DAPI (Sigma, St. Louis, MO) (10µg/mL in glycerol: PBS
1:1) and analyzed in the Zeiss LSM 510 confocal system
Meta/UV and in the inverted motorized microscope Zeiss -
Axiovert 200.
Quantitative Reverse-Transcription Polymerase Chain
Reaction
Cultured cells were lysed with Trizol (Invitrogen, Carlsbad,
CA) and total RNA was extracted as described by the
manufacturer. 2μg of RNA were reverse transcribed to cDNA
using random primers and oligodT and Superscript II reverse
transcriptase (Invitrogen, Carlsbad, CA). Relative mRNA levels
were assessed by quantitative reverse-transcription
polymerase chain reaction with SyBR Green master mix
(Applied Biosystems, Foster City, CA) in triplicates using an
ABI Prism 7700 (Applied Biosystems, Foster City, CA). Primers
for CD100, GAPDH, IL-1 β and STAT-1 (see below) were
CD100 in Human Atheromas
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designed using primerexpress software and purchased from
Invitrogen (Carlsbad, CA). Results were normalized using
GAPDH.
Primers:
CD100(F): 5’ CGAGAAGCAGCATGAGGTGTATTG 3’
CD100(R): 5’ CGGATGTAGTTGAGGCACTCTGTC 3’
STAT1(F): 5’ CAAGGTGGCAGGATGTCTCAG 3’
STAT1(R): 5’ TTCCATGGGAAAACTGTCATCAT 3’
GAPDH(F): 5’ TGGTCTCCTCTGACTTCAACA 3’
GAPDH(R): 5’ AGCCAAATTCGTTGTCATACC 3’
Western blotting
Cultured cells were washed with PBS and lysed with lysis
buffer (1% Nonidet P-40 (v/v), 50mM Tris (pH 7.4), 150mM
NaCl, 1mM EDTA, 1mM PMSF, 50 U/mL aprotinin and 1mM
leupeptin) for 30 min at 4°C. After centrifugation at 12000g to
remove cellular debris, the protein was quantified with BCA
(Pierce, Rockford, IL). 30μg of soluble protein was separated
by SDS-PAGE and electrotransferred to nitrocellulose
membranes (Amersham, Paris, France). The membranes were
blocked and incubated with the primary antibody anti-CD100
(BD Transduction, San Jose, CA), overnight at 4°C. After
washing, membranes were incubated with anti-mouse HRP-
conjugated secondary antibody for 1h at room temperature.
Blots were developed using chemiluminescence detection
system ECL (Amersham, Paris, France) followed by
autoradiography on x-ray film (Kodak, Cedex, France) and
scanning densitometry. The same blots were incubated with
anti-β-actin mouse anti-human antibody (Sigma, St. Louis, MO)
and developed as described.
Measurement of oxidized LDL incorporation
In vitro differentiated macrophages were incubated with
50μg/ml of oxLDL for differentiation into foam cells with or
without 10µg/ml of CD100 (Abnova, Taipei, Taiwan) for 48h (as
suggested by Dr Boumsell). The medium was removed and the
cells fixed with 10% formalin for 5 min at RT. Cells were then
washed with 60% isopropanol, allowed to dry, and stained with
Oil Red (Sigma O-0625, St. Louis, MO) for 10min. The wells
were repeatedly washed with distilled water, and Oil Red was
eluted with 100% isopropanol for 10min. The optical density
(OD) was measured at 500 ηm, 0.5sec. 100% isopropanol was
used as blank.
Statistics
Kolmogorov-Smirnov test was applied to verify if the group
samples presented normal distribution. In case of a Gaussian
distribution, parametric paired T-student test (two groups) or
ANOVA (more groups) were applied. Otherwise non-parametric
Wilcoxon (two groups) or Friedman (more groups) tests were
used. Correlation analyses between CD100 or STAT-1
expression along cell differentiation were performed using
Spearman’s (non-parametric test) or Pearson’s coefficient
(parametric test). P-values of 5% were considered significant.
Results
Phage display and plexin B1 phage
After two cycles of pre-clearing (subtraction) in normal
carotids and selection (panning) in atherosclerotic plaques, we
randomly selected and sequenced 100 phages among the
ones that bound to the plaques. All 100 phages were different
and alignment using ClustalW did not show important common
sequences or domains.
Comparison to public databases using BLASTp indicated
that one of the phages (phage B6, and only this phage)
presented four consecutive amino acids (ELGC) in nine
(CGFSGELGC) identical to plexin B1, rendering an alignment
score of 16.3. Since plexin B1 is a high affinity receptor for
CD100, we aimed to validate this finding by analyzing CD100
expression in atherosclerotic plaques.
Expression of CD100 in atherosclerotic plaques, spleen
and cultured cells
CD100 expression was investigated in tissue sections from
normal human carotid (Figure 1E, F) and coronary (Figure 1G,
H) arteries and the respective carotid (Figure 2E, F) and
coronary (Figure 2G, H) plaques. In most plaques analyzed
there were practically no T cells, but abundant macrophages
and foam cells. We observed positive cytoplasmic staining for
CD100 in the vast majority of the cells in the area of the
plaques occupied by foam cells (Figure 2E-H). In both normal
carotid and coronary samples analyzed CD100 was stained
mainly in endothelial cells (Figure 2E-H). Double staining
immunofluorescence using anti-CD68 and CD100 confirmed
that CD100 positively stained carotid plaque macrophages
(Figure 3).
We subsequently analyzed whether conventional, tissue-
resident macrophages also expressed CD100. Double staining
immunofluorescence experiments in human spleen tissue
sections for both CD100 and CD68 showed a great number of
double positive cells (Figure S1), which confirmed that most
spleen macrophages (CD68 positive) also expressed CD100.
However, single positive populations for each marker could
also be observed.
Next we analyzed CD100 expression in cultured monocytes
from peripheral blood and in vitro differentiated macrophages
and foam cells. Double staining immunofluorescence using
antibodies for CD68 and CD100 showed expression and co-
localization of both markers in all PB derived cell types (Figure
4A-L)
CD100 mRNA in cultured cells
We analyzed CD100 mRNA abundance using quantitative
RT-PCR in cultured monocytes, macrophages and foam cells,
and the effect of 24h activation with IFN-γ. Figure 5A shows
that monocytes express significantly more CD100 than
macrophages and foam cells (p values 0.018 and 0.028,
respectively), and this difference is still observed after
activation (p = 0.018). On the other hand, macrophages and
foam cells have similar transcript levels both in activated and
non-activated conditions. CD100 expression was inversely and
CD100 in Human Atheromas
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significantly (p ≤ 0.007) correlated with monocyte-macrophage-
foam cell differentiation with coefficients (rho) of -0.57 and
-0.68 for the non-activated and activated states, respectively.
Concerning activation, the only cell type that showed significant
increase (p = 0.018) in CD100 after IFN-γ treatment were
monocytes (Figure 5A). STAT-1 expression was assessed to
confirm activation by IFN-γ [26], and we observed a significant
higher expression in monocytes compared to macrophages (p
= 0.028) in non-activated and activated conditions. Increased
STAT-1 expression confirmed IFN-γ activation in monocytes
and in macrophages (p = 0.018 and 0.028, respectively)
(Figure 5B). Differently from what was observed for CD100,
Figure 1.  CD100 is expressed only in endothelia of normal coronary and carotid arteries.  CD100 labeling (E-H) and negative
controls (A-D) in normal carotid (A, B, E, F) and coronary (C, D, G, H) artery tissue sections by immunohistochemistry. Positive
CD100 staining was observed only in endothelia of normal arteries (arrowheads). Scale bars: 10µm (A, E, C and G) and 50µm (B,
F, D and H).
doi: 10.1371/journal.pone.0075772.g001
Figure 2.  Infiltrating cells of the intima in coronary and carotid plaques are CD100 positive.  CD100 labeling (E-H) and
negative controls (A-D) in artery tissue sections of carotid plaques (A, B, E, F) and coronary plaques (C, D, G, H) by
immunohistochemistry. Positive CD100 staining was observed only in preserved endothelium (arrowhead), and in infiltrating cells in
the intima (asterisks). Scale bars: 10µm (A, E, C and G), and 50µm (B, F, D and H).
doi: 10.1371/journal.pone.0075772.g002
Figure 3.  Macrophages and foam cells from atherosclerotic plaques express CD100.  Immunofluorescence of carotid plaques
with blue nuclei in DAPI (A), CD68 staining in FITC (green, B), CD100 staining in Alexa 660 (red, C) and co-localization of markers
(D). Scale bars: 20µm.
doi: 10.1371/journal.pone.0075772.g003
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there was a negative correlation (rho = -0.71 with a p = 0.002)
in the pattern of expression of STAT-1 along differentiation only
in the activated state but not in non-stimulated cells (rho = -0.2
with a p = 0.426). The most activated cells according to
STAT-1 expression were also the ones that expressed the
highest levels of CD100.
CD100 protein in cultured cells
We then compared CD100 protein abundance in lysates of
PB monocytes, macrophages and foam cells, that would
represent a sum of intracellular and membrane CD100, not
including the soluble form. T lymphocytes stimulated or not with
CD3/CD28 beads were used as positive control.
In Jukart cells and other cell types, mCD100 migrates as a
150kDa monomeric form and the soluble form (sCD100) as
120kDa form, under reducing conditions [27]. Accordingly, we
detected two bands of approximately 150kDa and 120kDa in
PB derived cells (Figure 6A). We observed statistically similar
levels of CD100 in monocytes, macrophages and foam cells
(Figure 6B). In fact, there was no significant negative
correlation between CD100 protein expression and
differentiation (r = -0.617, with a p = 0.077). Unfortunately, the
low yield of monocytes, macrophages and foam cells did not
render sufficient protein for both non-activated and IFN-γ
activated conditions.
CD100 decreases LDLox uptake by macrophages and
foam cell formation
Although CD100 expression was verified in plaque and
cultured macrophages as well as its upregulation under pro-
inflammatory stimuli, the effects of macrophage and foam cell-
derived CD100 remained unclear. To verify whether soluble
CD100 shed by these cells would have any effect on the
uptake of oxLDL by macrophages, macrophages were
differentiated into foam cells in the presence or not of
recombinant CD100 to quantify the uptake of oxLDL using Oil
Red O. As can be seen in Figure 7, oxLDL uptake was reduced
in the presence of CD100 in all experiments, showing a
suppressive effect in the LDL-induced foam cell differentiation.
CD100 decreases ox LDL induced CD36 expression in
macrophages
To identify the mechanism by which CD100 down-regulates
macrophage oxLDL uptake we analyzed CD36 mRNA
expression (which is known to be induced by oxLDL) in these
cells and in differentiated foam cells after CD100 treatment.
Macrophages and foam cells were incubated with oxLDL with
either CD100 or IL-10 (a CD36 down-regulator) (Figure 8A and
B). As shown in Figure 8, CD100 and IL-10 significantly
diminished CD36 expression in macrophages (Figure 8A) but
not in foam cells (Figure 8B).
Figure 4.  In vitro cultured monocytes, macrophages and foam cells express CD100.  Immunofluorescence of PB monocytes
(A-D), macrophages (E-H) and foam cells (I-L) showing blue nuclei in DAPI (A, E, I), CD68 (green; B, F, J), CD100 (red; C, G, K)
and co-localization of all markers in D, H and L. Scale bars: 5µm.
doi: 10.1371/journal.pone.0075772.g004
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Discussion
Phage display has proven to be an efficient tool for the
identification of markers for several tissues and cell types
[7–10]. The use of fresh human tissues (ex vivo) [28–31]or
mouse models (in vivo) [7,8,28,32,33]for phage selection
enhances the possibility of finding a peptide/antibody that can
bind to human tissues in vivo, improving the diagnosis of the
associated diseases. Such strategies have been successfully
employed for tumors [28], and even for atherosclerosis [32,34].
In this work, phage technology indicated increased CD100
expression in fresh human carotid plaque samples. Despite the
available studies in animal models, our study is the first to
describe CD100 expression in human atherosclerotic plaques
and to speculate a role for the molecule in the human disease.
In fact, we observed remarkable CD100 expression in the lipid
rich area of the plaques, particularly in macrophages and foam
cells, whereas in the normal samples positive staining was
observed only in endothelial cells. The isolation of a CD100
binding phage after subtraction using normal carotid (that
express CD100 in endothelial cells) and panning of carotid
plaques (that express CD100 mainly in macrophages and foam
cells) may have been possible because macrophages and
foam cells express more CD100 than endothelial ones (data
not shown). This result is in line with previous data that show
CD100 distinct activities in the immune system and its
significant association in vascular phenomena.
Figure 5.  Resting and IFN-γ stimulated monocytes show
increased levels of CD100 mRNA compared to
macrophages and foam cells (A, B).  Quantitative RT-PCR
(qRT-PCR) for CD100 (A) or STAT-1 (B) in PB monocytes,
macrophages and foam cells stimulated (+) or not (-) with IFN-
γ. Folds relative to non stimulated monocytes (mono-),
normalized with GAPDH. (a) * = significant p values (p≤0.05) in
the comparisons in unstimulated and stimulated conditions.
doi: 10.1371/journal.pone.0075772.g005
Figure 6.  Cultured monocytes express higher amounts of
CD100 protein than in vitro differentiated macrophages
and foam cells.  CD100 and β-actin protein expression was
evaluated in activated T lymphocytes (TL – positive control)
and PB monocytes (Mono), macrophages (Mac) and foam cells
(Foam) A. Western blot showing CD100 and β-actin bands B.
Densitometry of CD100 (sum of 120 and 150kDa bands) and β-
actin protein bands, showing CD100/β-actin. Mean ± SD of 3
independent experiments.
doi: 10.1371/journal.pone.0075772.g006
Figure 7.  CD100 protein reduces oxLDL incorporation in
macrophages.  Optical density indicating incorporation of
oxLDL by PB macrophages incubated or not with oxLDL or
oxLDL and CD100. Mean ± SD of 5 independent experiments
(*** p≤0.001).
doi: 10.1371/journal.pone.0075772.g007
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CD100 had already been described in monocytes [14] and
tumor associated macrophages [18], but not in other
macrophages. CD100 positivity in splenic macrophages (Figure
S1) suggested that the molecule is expressed by macrophages
in general.
Monocytes, cultured macrophages and in vitro differentiated
foam cells also showed positive staining for CD100, suggesting
that the molecule participates in the different stages of the
disease. Monocytes expressed the highest levels of CD100
RNA also after IFN-γ activation, suggesting important roles for
the molecule in this cell type. Foam cells did not augment
CD100 upon IFN-γ, and were also the least responsive cell
type, as seen by STAT-1 levels. These results show that
distinct cells respond differently to IFN-γ activation in terms of
CD100 expression. Additionally, CD100 expression
significantly diminished along monocyte-macrophage-foam cell
differentiation, regardless of their activation state.
Figure 8.  (A, B): CD36 mRNA is reduced in cultured
macrophages treated with oxLDL in the presence of CD100
and IL-10.  Relative quantitative RT-PCR (qRT-PCR) for CD36
in macrophages (A) and foam cells (B) incubated with oxLDL in
the presence of CD100 or IL-10. Data normalized with GAPDH
and expressed as a ratio (fold) relative to cells incubated only
with oxLDL. Mean ± SD of 3 independent experiments (**
p≤0.01).
doi: 10.1371/journal.pone.0075772.g008
CD100 protein was detected in monocytes, macrophages
and foam cells but showed no correlation to differentiation,
contrarily to RNA data. Possible hypotheses for the lack of
agreement between RNA and protein could be cleavage and
shedding of the membrane CD100 by metalloproteases, later
translation of CD100 transcripts than the time analyzed, or
instability of CD100 transcripts, which would be more
susceptible to degradation than the protein itself. Further
experiments are needed to confirm one or more hypotheses.
Since the accumulation of lipid-laden macrophages is the
first step of atherogenesis, we hypothesized whether CD100
could affect this process. CD100 treatment actually reduced
LDL-induced foam cell formation. The mechanism by which this
semaphorin reduces lipid uptake is probably by down-
regulating the expression of CD36, a scavenger receptor with
central role in oxLDL binding and atherogenesis. Despite CD36
importance in immune responses and vascular biology, there is
surprisingly little knowledge regarding the regulation of its
expression, and its modulation by CD100 was a novel finding.
Further studies should be performed regarding possible uses of
CD100 in anti-atherogenic therapies.
Supporting Information
Figure S1.  CD100 is expressed by splenic macrophages.
Immunofluorescence of spleen (A-D), showing blue nuclei in
DAPI (A), CD68 (green, B) and CD100 (red, C). The yellow
color in the merged images (bottom right panel, D) denotes co-
localization. Scale bars 20μm.
(TIF)
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